6-oxo-PGF1 αand 8-epi-PGF2 αin the arterial wall layers of various species: a comparison between intact and atherosclerotic areas
Authors:
- H. SinzingerHSH. Sinzinger
- 31 March 2001
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 64 (3) , 167-171
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries isolated from patients with coronary heart diseaseCardiovascular Research, 1999
- Localization of distinct F2-isoprostanes in human atherosclerotic lesions.Journal of Clinical Investigation, 1997
- Hemodynamic Effects of Isoprostanes (8-Iso-Prostaglandin F2α and E2) in Isolated Guinea Pig HeartsJournal of Cardiovascular Pharmacology, 1997
- THE INFLUENCE OF ISOPROSTANES ON ADP-INDUCED PLATELET AGGREGATION AND CYCLIC AMP-GENERATION IN HUMAN PLATELETSThrombosis Research, 1997
- Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative DamageNew England Journal of Medicine, 1995
- Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 ReleaseJournal of Cardiovascular Pharmacology, 1995
- Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-IsoprostaneBiochemical and Biophysical Research Communications, 1993
- The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonistProstaglandins, 1992
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- Quantitative morphological investigations on smooth muscle cells in vascular surgical specimens and their clinical importanceCellular and Molecular Life Sciences, 1975